Accéder au contenu
Merck

Understanding and Sensitizing Density-Dependent Persistence to Quinolone Antibiotics.

Molecular cell (2017-12-12)
Arnaud Gutierrez, Saloni Jain, Prerna Bhargava, Meagan Hamblin, Michael A Lobritz, James J Collins
RÉSUMÉ

Physiologic and environmental factors can modulate antibiotic activity and thus pose a significant challenge to antibiotic treatment. The quinolone class of antibiotics, which targets bacterial topoisomerases, fails to kill bacteria that have grown to high density; however, the mechanistic basis for this persistence is unclear. Here, we show that exhaustion of the metabolic inputs that couple carbon catabolism to oxidative phosphorylation is a primary cause of growth phase-dependent persistence to quinolone antibiotics. Supplementation of stationary-phase cultures with glucose and a suitable terminal electron acceptor to stimulate respiratory metabolism is sufficient to sensitize cells to quinolone killing. Using this approach, we successfully sensitize high-density populations of Escherichia coli, Staphylococcus aureus, and Mycobacterium smegmatis to quinolone antibiotics. Our findings link growth-dependent quinolone persistence to discrete impairments in respiratory metabolism and identify a strategy to kill non-dividing bacteria.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Gentamicine sulfate salt, powder, BioReagent, suitable for cell culture